# Spark Therapeutics, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd

> Inspection records and compliance data for Spark Therapeutics, Inc. in Philadelphia, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: Spark Therapeutics, Inc.
- FEI Number: 3011194531
- City: Philadelphia
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 3737 Market St Ste 1300
- Zip Code: 19104

## Related Documents

- [FDA Inspection 1289380 - Spark Therapeutics, Inc. - 2025-10-30](https://www.keypedia.com/records/fda_inspections/spark-therapeutics-inc/fa196f80-255c-4098-853a-63f00b976ff7) — source: FDA, date: October 30, 2025
- [483 - Spark Therapeutics, Inc. - 2022-03-04](https://www.keypedia.com/records/483/spark-therapeutics-inc/8dd2825e-0b1c-4ca2-b73c-ea234760ec56) — source: FDA, date: March 4, 2022
- [FDA Inspection 1171797 - Spark Therapeutics, Inc. - 2022-03-04](https://www.keypedia.com/records/fda_inspections/spark-therapeutics-inc/1a56c342-57f0-4c4d-be0b-3e75d182a188) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 4, 2022
- [FDA Inspection 1171797 - Spark Therapeutics, Inc. - 2022-03-04](https://www.keypedia.com/records/fda_inspections/spark-therapeutics-inc/ae7bc291-fbda-42c3-885c-6d8f574bf1c3) — classification: No Action Indicated (NAI), source: FDA, date: March 4, 2022
- [483 - Spark Therapeutics, Inc. - 2017-08-25](https://www.keypedia.com/records/483/spark-therapeutics-inc/2e64b039-fc19-4296-a3fc-b464ff3748c1) — source: FDA, date: August 25, 2017

## Related Companies

- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Biogen MA Inc.](https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264)
- [UQUIFA Mexico, S.A. de C.V.](https://www.keypedia.com/companies/uquifa-mexico-sa-de-cv/8523a240-e52a-495e-a781-e12c6412dc69)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [MSN Laboratories Private Limited, Unit-II](https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a)
- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)

## Related Officers

- [Zeneida Torrapravata, PhD](https://www.keypedia.com/people/zeneida-torrapravata-phd/db18f9c0-bebd-4228-ad66-5cdf5de2d586)
- [Lilia Bi, PhD](https://www.keypedia.com/people/lilia-bi-phd/7607e3c9-1322-4ec5-892b-6a35e28eecff)
- [Principal Consultant- CMC Biologics, Former FDA regulator with expertise in CMC and GMP for Biologics](https://www.keypedia.com/people/steven-e-bowen/0e32c7e6-285b-4cf1-90e1-8a7a12a38b0c)
- [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)